Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Arcturus Therapeutics Holdings Inc. (ARCT) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.06M |
|
$-26.96M |
|
-- |
|
$2.06M |
|
$30.99M |
|
$-28.93M |
|
$1.97M |
|
$-26.96M |
|
$-26.96M |
|
$-26.96M |
|
$-26.96M |
|
$-26.96M |
|
$-26.96M |
|
$-28.93M |
|
$-28.27M |
|
28.42M |
|
28.42M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$216.88M |
|
$6.08M |
|
$28.53M |
|
$245.41M |
|
$34.37M |
|
-- |
|
$19.68M |
|
$54.05M |
|
$191.36M |
|
$191.36M |
|
$191.36M |
|
28.42M |
|
| Cash Flow Statement Financials | |
$-19.44M |
|
$0.03M |
|
$0.02M |
|
$232.79M |
|
$213.40M |
|
$-19.39M |
|
$4.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.31 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-1403.74% |
|
-1403.74% |
|
-- |
|
-1308.30% |
|
-1308.30% |
|
$-19.41M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.53 |
|
58.65 |
|
-14.09% |
|
-14.09% |
|
-10.99% |
|
-14.09% |
|
$6.73 |
|
$-0.68 |
|
$-0.68 |
|